Cargando…

Intraocular Pressure Effects and Mechanism of Action of Topical Versus Sustained-Release Bimatoprost

PURPOSE: To assess the intraocular pressure (IOP)-lowering effects of bimatoprost sustained-release implant (BimSR) in normotensive monkeys receiving topical bimatoprost. METHODS: Six eyes from six female, normotensive, cynomolgus monkeys were treated with once-daily topical latanoprost 0.005% plus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Susan S., Almazan, Alexandra, Decker, Sherri, Zhong, Yan, Ghebremeskel, Alazar N., Hughes, Patrick, Robinson, Michael R., Burke, James A., Weinreb, Robert N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355114/ https://www.ncbi.nlm.nih.gov/pubmed/30713809 http://dx.doi.org/10.1167/tvst.8.1.15

Ejemplares similares

Dose–Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure
por: Lee, Susan S., et al.
Publicado: (2019)

Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
por: Ghosn, Corine, et al.
Publicado: (2022)

Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure
por: Tung, Jonathan D, et al.
Publicado: (2012)

Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
por: Seal, Jennifer R., et al.
Publicado: (2019)

Proposed Mechanism of Long-Term Intraocular Pressure Lowering With the Bimatoprost Implant
por: Stamer, W. Daniel, et al.
Publicado: (2023)

24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
por: Craven, E. Randy, et al.
Publicado: (2019)

Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides
por: Smid, Scott D
Publicado: (2009)

Nonclinical Pharmacokinetic and Pharmacodynamic Assessment of Bimatoprost Following a Single Intracameral Injection of Sustained-Release Implants
por: Shen, Jie, et al.
Publicado: (2020)

Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% — an observational switch study
por: Deshpande, Sarita S, et al.
Publicado: (2017)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors
por: Chang-Lin, Joan-En, et al.
Publicado: (2011)

Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies
por: Weinreb, Robert N., et al.
Publicado: (2023)

Periorbital muscle atrophy associated with topical bimatoprost therapy
por: Wang, Priscilla Xinhui, et al.
Publicado: (2014)

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events
por: Tsumura, Toyoaki, et al.
Publicado: (2012)

Diurnal Intraocular Pressure with Bimatoprost/Timolol Fixed Combination versus Latanoprost/Timolol Fixed Combination in Healthy Subjects
por: Shim, Seong Hee, et al.
Publicado: (2014)

Fixed-combination treatments for intraocular hypertension in Chinese patients – focus on bimatoprost-timolol
por: Fang, Yuan, et al.
Publicado: (2015)

First-line treatment for elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension: focus on bimatoprost
por: Law, Simon K
Publicado: (2007)

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. [Corrigendum]
Publicado: (2013)

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events [Corrigendum]
Publicado: (2013)

Comparative study of the efficacy and safety of topical minoxidil 2% versus topical bimatoprost 0.01% versus topical bimatoprost 0.03% in treatment of eyebrow hypotrichosis: a randomized controlled trial
por: Zaky, Mohamed S., et al.
Publicado: (2023)

Bimatoprost in Dermatology
por: Jha, Abhijeet K., et al.
Publicado: (2018)

Efficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360° synechial angle-closure glaucoma: A preliminary study
por: Vyas, Prateep, et al.
Publicado: (2011)

Bimatoprost-Loaded Ocular Inserts as Sustained Release Drug Delivery Systems for Glaucoma Treatment: In Vitro and In Vivo Evaluation
por: Franca, Juçara Ribeiro, et al.
Publicado: (2014)

Rapid and Accurate Pressure Sensing Device for Direct Measurement of Intraocular Pressure
por: Gopesh, Tilvawala, et al.
Publicado: (2020)

Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs
por: Lee, Susan S., et al.
Publicado: (2019)

Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China
por: Wang, Kaidi, et al.
Publicado: (2014)

Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose–response phenomenon
por: Shen, Jie, et al.
Publicado: (2016)

Corneal Alterations Induced by Topical Application of Commercial Latanoprost, Travoprost and Bimatoprost in Rabbit
por: Chen, Wensheng, et al.
Publicado: (2014)

Idiopathic Guttate Hypomelanosis Treated with 308-nm Excimer Light and Topical Bimatoprost
por: Kreeshan, Firas Constantin, et al.
Publicado: (2021)

Effect of eyelid muscle action and rubbing on telemetrically obtained intraocular pressure in patients with glaucoma with an IOP sensor implant
por: van den Bosch, Jacqueline J O N, et al.
Publicado: (2023)

Topical intraocular pressure therapy effects on pregnancy
por: Mendez-Hernandez, Carmen, et al.
Publicado: (2012)

Correction: Corneal Alterations Induced by Topical Application of Commercial Latanoprost, Travoprost and Bimatoprost in Rabbit
Publicado: (2014)

The effect of daily life activities on intraocular pressure related variations in open-angle glaucoma
por: Gillmann, Kevin, et al.
Publicado: (2021)

An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan(®) RC Early Analysis Review (CLEAR) trial
por: Crichton, Andrew C, et al.
Publicado: (2014)

Intraocular Pressure Change and Sustained Intraocular Pressure Elevation After Pars Plana Vitrectomy
por: Cabuk, Kubra Serefoglu, et al.
Publicado: (2021)

Bimatoprost in the treatment of eyelash hypotrichosis
por: Law, Simon K
Publicado: (2010)

Bimatoprost Implant: First Approval
por: Shirley, Matt
Publicado: (2020)

Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
por: Perera, Shamira A, et al.
Publicado: (2016)

Clinical investigation of the effect of topical anesthesia on intraocular pressure
por: Almubrad, Turki M, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_uts0igg75lmkunjc7osv94c6bb